Global E-cigarette Market Weekly (1.15-1.21)

Industry Insight by 2FIRSTS
Jan.22.2024
Global E-cigarette Market Weekly (1.15-1.21)
In a challenging market, big cigarette brands are entering Japan, while Malaysia pushes for e-liquid regulation. Can Korea's e-cigarette market rise in 2024?

The "credit society" with airtight regulations, stringent production conditions, and advertisers who constantly switch channels make it challenging for new tobacco brands to enter the Japanese market. However, as small brands face entry barriers and believe in the vast market potential after the relaxation of zero nicotine restrictions, established brands have started to seize this opportunity and expand their distribution.

 

The Malaysian E-Cigarette Consumers Association has announced that they have shared the findings of the 2FIRSTS report with local consumers and will continue to advocate for local e-liquid regulations.

 

In 2023, multiple well-known disposable e-cigarette brands such as ELFBAR and VUSE have entered the South Korean market. Simultaneously, South Korean conglomerates are also actively establishing their presence in the e-cigarette industry. This series of developments has the potential to disrupt the existing landscape of the South Korean e-cigarette market. In light of these changes, the question arises: Can the South Korean e-cigarette market thrive in 2024?

 

On January 18th, a backbench debate took place in the British Parliament, allowing backbench MPs to raise local or national issues and receive responses from relevant government ministers. The debate focused on the regulation of e-cigarettes in the UK, the World Health Organization (WHO), and the contrasting views between the organization and the British government regarding e-cigarettes.

 

On January 18, 2024, 2FIRSTS and CNR News held a signing ceremony for the ESG projects in the vaping industry, accompanied by the release of the "2023 Global Vaping Industry ESG Development Report" at the CNR News headquarters in Beijing. The event was attended by Wu Gang, Deputy Editor-in-Chief of CNR News, Zhao Tong, Co-founder and CEO of 2FIRSTS, Hu Lishan, Senior Director of the Financial and Economic Department at CNR News, and Hou Yuhuan, Global Vice President and Executive Editor-in-Chief of 2FIRSTS.

 

Blu's former factory, Tianchang Group, experiences a 79% decrease in e-cigarette sales and plans to seek new customers to expand its customer base.

 

The U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to SMOK, a manufacturer of 22 e-cigarette products. Please refer to the detailed list at the end of the article.

 

Guangdong Liwang New Energy Co., Ltd. received three institutional visits and highlighted its advantages and future plans in the lithium-ion battery business.

 

Vuse Go 800 is set to be widely available in South Korea, with distribution expanding to include 30,000 convenience stores and tobacco shops throughout the country.

 

SKE, a company specializing in electronic atomizer components, has announced its plan to establish an industrial park in Guangshui City, Hubei Province, with a total investment of 1 billion RMB.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29